A distinguished professional Seminar Series is co-sponsored by
the Institute for Hepatitis and Virus Research, Hepatitis B Foundation,
and the Drexel Institute to promote scientific exchange at a national
and international level. National and international leaders in the
field are invited to speak on a regular schedule.
Seminar Series Schedule 2009
January 8 - 11:00 AM - Chuck Reynolds, PhD (Johnson & Johnson)
"Application of Computer Modeling in Drug Discovery"
January 30 - 11:00 AM - Yvonne Paterson, PhD (Dept. of Microbiology, University of Pennsylvania School of Medicine
"A Multi-pronged Approach to Tumor Immunotherapy Using Listeria Monocytogenes as an Antigen Delivery Vehicle"
February 13 - 11:00 AM - Sandhya Kortagere, PhD (Microbiology and Immunology, Drexel University College of Medicine
"Hybrid Structure Based Method and its Application to Design New Lead Compounds"
March 3 - 11:00 AM - Brian Haab, PhD (Laboratory of Cancer Immunodiagnostics, Van Andel Institute)
"The Prevalence and Nature of Glycan Alterations on Specific Proteins in Pancreatic Cancer Patients Revealed Using Antibody-Glycan Sandwich Arrays"
March 11 - 11:00 AM - Wai Law, PhD (PortaScience, Inc.)
"Point-of-Care Testing for WBCs"
March 11 - 3:00 PM - Nathalie Scholler, MD, PhD (Obstetrics and Gynecology, University of Pennsylvania School of Medicine)
March 16 - 11:00 AM - Raj Mutharason, PhD (Chemical and Biological Engineering, Drexel University)
"Piezoelectric-Excited Millimeter-Sized Cantilever (PEMC) Sensors for Detecting Pathogens and Biomarkers at Femtogram Levels"
March 19 - 4:00 PM - Dr. Stephen Locarnini (Victorian Infectious Diseases Reference Laboratory / WHO Collaborating Centre for Virus Reference & Research)
"The Virology of Hepatitis B Immunomodulation and Therapy"
Hepatitis B Foundation's 2009 Bruce Witte Lecturer
March 25 - 11:00 AM - Dr. Wolfram Gerlich (Institute for Medical Virology, Geissen, Germany)
"Escape Mutants in Occult and Reactivated Hepatitis B Virus Infection"
April 8 - 11:00 AM - Dr. Harvey Friedman (Infectious Disease Division, University of Pennsylvania School of Medicine)
"Translating Basic Discoveries of HSV-2 Pathogenesis Into an HSV-2 Vaccine"
April 16 - 11:00 AM - Paul Ahlquist, PhD (Institute for Molecular Virology, University of Wisconsin)
"Viral and Host Functions in RNA and Reverse-Transcribing Virus Replication"
April 27 - 11:00 AM - Raymond Dwek, FRS (Oxford Glycobiology Institute, University of Oxford)
"Glycobiology - Leading to Novel Therapies for Hepatitis and HIV"
May 20 - 11:00 AM - Dr. David Kaplan (Gastroenterology Division, University of Pennsylvania School of Medicine)
"Dysfunctional Tumor Antigen-Specific T-Cell Responses in Hepatocellular Carcinoma"
May 27 - 11:00 AM - Bart DeCorte, PhD (Pharmaceutical Research & Development, Johnson & Johnson)
"The Long Road to Intelence®, a Next-Generation NNRTI for the Treatment of HIV"
June 22 - 11:00 AM - Terry Butters, PhD (Glycobiology Institute, University of Oxford)
"Therapeutic Potential of Protein Folding Inhibitors"
June 26 - 11:00 AM - Dr. Michael Fried (University of North Carolina at Chapel Hill)
"HBV Treatment Guidelines: Navigating the Twilight Zone"
July 16 - 11:00 AM - Gary Jacob, PhD (Synergy Pharmaceuticals, Inc.)
"What a Lifetime in Drug Development Has Taught Me...Or, What They Don't Teach You in Graduate School"
August 19 - 11:00 AM - Stephen Lee, PhD (OraSure Technologies, Inc.)
"Recent Developments in Point of Care Testing for HIV and Hepatitis"
September 16 - 11:00 AM - Bruce Maryanoff, PhD (Johnson & Johnson Pharmaceutical Research & Development)
"An Odyssey in Drug Discovery Through Serine-Protease Space"
September 18 - 8:30 AM - 2009 Annual Regional Biotech Conference
"A Roadmap for Biotechnology Ventures"
September 23 - 11:00 AM - Luis Montaner, DVM (The Wistar Institute)
"Innate Immune Effectors and HIV-1: From Viral Replication to ART and Back"
September 30 - 11:00 AM - James Arthos, PhD (Laboratory of Immunoregulation, NIAID, NIH)
"The Role of Integrin Alpha4beta7 in HIV-1 Transmission"
October 5 - 11:00 AM - James Barrett, PhD (Drexel University College of Medicine)
"Development of Drugs to Treat Cognitive Disorders Associated with Psychiatric and Neurological Diseases"
October 15 - 11:00 AM - Daniel Flynn, PhD (Commonwealth Medical College)
"Defining the Cellular Function of AFAP1:A Potential Drug Target for Breast and Ovarian Cancer"
October 21 - 11:00 AM - Rene Daniel, MD, PhD (Thomas Jefferson University, Jefferson Medical College)
"Epigenetics in Gene Transfer and Stem Cell Differentiation"
October 29 - 11:00 AM - Hie-Won Hann, MD (Thomas Jefferson University, Jefferson Medical College)
"Antiviral Therapy for Hepatitis B and Hepatocellular Carcinoma"
November 2 - 11:00 AM - Maria Maccecchini, PhD (President & CEO, QR Pharma)*
"Pathways Leading to Alzheimer's Disease"
November 12 - 11:00 AM - D. Craig Hooper, PhD (WHO Center for Neurovirology, Thomas Jefferson University)
"Delivery of Therapeutics Across the Blood-Brain Barrier by Immune Mechanisms"
November 19 - 4:00 PM - Allen Reitz, PhD (ALS BioPharma)*
"The Pennsylvania Center for Drug Discovery: Public Private Partnerships to Accelerate Innovation"
November 30 - 11:00 AM - Melik Demirel, PhD (Penn State University)
"Pathogen Sensing Via Ramen Activated Nanoparticles (RANs)"
December 17 - 11:00 AM - Lin Li, PhD (University of Pennsylvania)
"Novel Biomarkers of Cancer Metastatic Potential by MR/Optical Imaging"
December 21 - 4:00 PM - Herb Taylor, PhD (VP, Federal Reserve Bank of Philadelphia)*
"Outlook For The U.S. Economy "
For More Information:
Institute for Hepatitis and Virus Research
3805 Old Easton Road, Doylestown, PA 18902
* = Regional Biotech Council (RBC) Seminar Speakers (Registration may be required)
**= PA Center for Drug Discovery Seminar Speakers
Please note that all Seminars are held at the IHVR and Drexel Institute
located at the PA Biotechnology
Center of Bucks County in Doylestown, PA. Click
here for Travel Directions.